SRNE · Categories · Form 5

SRNE - SEC Form 5 annual insider statements

Sorrento Therapeutics Inc. (SRNE) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.

Recent Form 5 for SRNE

• 1214d
  SEC Form 5: Janda Kim closing all direct ownership in the company

  5 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)

Other SRNE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• DEF 14A
• M&A
• Earnings
• Dividends